| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |